Physiological and Reproductive Effects of Beta Adrenergic Receptor Antagonists in Daphnia magna

[1]  M. Cleuvers.  Initial risk assessment for three β-blockers found in the aquatic environment , 2005 .

[2]  A. Campbell,et al.  Lactose causes heart arrhythmia in the water flea Daphnia pulex. , 2004, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[3]  D. Makuc,et al.  Health, United States, 2004; with chartbook on trends in the health of Americans , 2004 .

[4]  D. Baird,et al.  Experimental Designs to Assess Endocrine Disrupting Effects in Invertebrates A Review , 2004, Ecotoxicology.

[5]  A. Pollio,et al.  Environmental risk assessment of six human pharmaceuticals: Are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment? , 2004, Environmental toxicology and chemistry.

[6]  J. Cook,et al.  A Theoretical Model for Utilizing Mammalian Pharmacology and Safety Data to Prioritize Potential Impacts of Human Pharmaceuticals to Fish , 2003 .

[7]  J. Reyes,et al.  The heart of Daphnia magna: effects of four cardioactive drugs. , 2003, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[8]  Jun-shi Chen,et al.  Fish consumption, blood docosahexaenoic acid and chronic diseases in Chinese rural populations. , 2003, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.

[9]  Jacob K Stanley,et al.  Aquatic ecotoxicology of fluoxetine. , 2003, Toxicology letters.

[10]  B. Brooks,et al.  Comparison of in vitro and in vivo bioassays for estrogenicity in effluent from North American municipal wastewater facilities. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[11]  D. Schlenk,et al.  Determination of beta-adrenergic receptor blocking pharmaceuticals in United States wastewater effluent. , 2003, Environmental pollution.

[12]  B. Brooks,et al.  Toxicity of Select Beta Adrenergic Receptor-Blocking Pharmaceuticals (B-Blockers) on Aquatic Organisms , 2002, Archives of environmental contamination and toxicology.

[13]  E. Thurman,et al.  Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. , 2002, Environmental science & technology.

[14]  R. Pirow,et al.  Benefits of haemoglobin in the cladoceran crustacean Daphnia magna. , 2001, The Journal of experimental biology.

[15]  J. Spicer.  Development of Cardiac Function in Crustaceans: Patterns and Processes1 , 2001 .

[16]  R. Altenburger,et al.  Alterations of physiological energetics, growth and reproduction of Daphnia magna under toxicant stress. , 2001, Aquatic toxicology.

[17]  Spicer,et al.  Hypoxia accelerates the development of respiratory regulation in brine shrimp - but at a cost , 1999, The Journal of experimental biology.

[18]  T. Ternes,et al.  Pharmaceuticals and personal care products in the environment: agents of subtle change? , 1999, Environmental health perspectives.

[19]  Pirow,et al.  The sites of respiratory gas exchange in the planktonic crustacean daphnia magna: an in vivo study employing blood haemoglobin as an internal oxygen probe , 1999, The Journal of experimental biology.

[20]  D Jordan,et al.  Central control of the cardiovascular and respiratory systems and their interactions in vertebrates. , 1999, Physiological reviews.

[21]  A. D. Vethaak,et al.  Analysis and occurrence of estrogenic hormones and their glucuronides in surface water and waste water in The Netherlands. , 1999, The Science of the total environment.

[22]  T. Ternes.  Occurrence of drugs in German sewage treatment plants and rivers 1 Dedicated to Professor Dr. Klaus , 1998 .

[23]  J. Wilkens.  Regulation of the Cardiovascular System in Crayfish , 1995 .

[24]  I. Brorens,et al.  The deceleration of the heart frequency in the waterfleaDaphnia magna by adrenoceptor agonists and antagonists , 1989, Hydrobiologia.

[25]  M. Wood,et al.  Stereoselective blockade of central [3H]5‐hydroxytryptamine binding to multiple sites (5‐HT1A, 5‐HT1B and 5‐HT1C) by mianserin and propranolol , 1987, The Journal of pharmacy and pharmacology.

[26]  John A. H. Lee.  Health: United States , 1986 .

[27]  G. M. Goodwin,et al.  A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5‐HT1 and 5‐HT2 receptors , 1985, British journal of pharmacology.

[28]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1976 .

[29]  Joel W. Hedgpeth,et al.  The physiology of Crustacea , 1962 .

[30]  J. M. Bekker,et al.  Physiological investigations into the heart function of Daphnia , 1951, The Journal of physiology.

[31]  E. R. Baylor.  CARDIAC PHARMACOLOGY OF THE CLADOCERAN, DAPHNIA , 1942 .

[32]  Karpjoo Jeong,et al.  Molecular Modeling of the Chiral Recognition of Propranolol Enantiomers by a β-Cyclodextrin , 2003 .

[33]  W. Waller,et al.  Assessment of Toxicity Reduction in Wastewater Effluent Flowing Through a Treatment Wetland Using Pimephales promelas, Ceriodaphnia dubia, and Vibrio fischeri , 2002, Archives of environmental contamination and toxicology.

[34]  W. Verstraete,et al.  Pharmaceuticals in the Environment: Focus on 17α-ethinyloestradiol , 2001 .

[35]  K. Kümmerer.  Pharmaceuticals in the Environment , 2001 .

[36]  M. Leider.  Goodman & Gilman's The Pharmacological Basis of Therapeutics , 1985 .

[37]  I. Burton,et al.  Environmental risk assessment , 1980 .

[38]  Donald M. Maynard,et al.  CHAPTER 5 – CIRCULATION AND HEART FUNCTION , 1960 .